Earlier this week, Johnson & Johnson announced a reduction in the price for bedaquiline in low- and middle-income countries, as part of a collaboration with the Stop TB Partnership's Global Drug Facility (GDF). The immediate change in price will make bedaquiline available through the GDF at the...
News about 'gdf'
20 May 2010
Dr Klaus M Leisinger, President and Managing Director of the Novartis Foundation for Sustainable Development, and Dr Hiro Nakatani, WHO Assistant Director-General Dr Klaus M Leisinger, President and Managing Director of the Novartis Foundation for Sustainable Development , and Dr Hiro Nakatani, WHO...